Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Lancet. 2010 Feb 6;375(9713):500-12. doi: 10.1016/S0140-6736(09)60996-X. Epub 2009 Nov 2.

Pulmonary embolism in pregnancy.

Author information

  • 1Department of Medicine, The Warren Alpert Medical School of Brown University, Women and Infants Hospital of Rhode Island, Providence, RI 02905, USA. GBourjeily@wihri.org

Abstract

Pulmonary embolism (PE) is the leading cause of maternal mortality in the developed world. Mortality from PE in pregnancy might be related to challenges in targeting the right population for prevention, ensuring that diagnosis is suspected and adequately investigated, and initiating timely and best possible treatment of this disease. Pregnancy is an example of Virchow's triad: hypercoagulability, venous stasis, and vascular damage; together these factors lead to an increased incidence of venous thromboembolism. This disorder is often suspected in pregnant women because some of the physiological changes of pregnancy mimic its signs and symptoms. Despite concerns for fetal teratogenicity and oncogenicity associated with diagnostic testing, and potential adverse effects of pharmacological treatment, an accurate diagnosis of PE and a timely therapeutic intervention are crucial. Appropriate prophylaxis should be weighed against the risk of complications and offered according to risk stratification.

Copyright 2010 Elsevier Ltd. All rights reserved.

Comment in

  • Pulmonary embolism in pregnancy. [Lancet. 2010]
  • Pulmonary embolism in pregnancy. [Lancet. 2010]
  • Pulmonary embolism in pregnancy. [Lancet. 2010]
PMID:
19889451
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk